跳至主要内容
临床试验/ACTRN12618000062224
ACTRN12618000062224已完成未知

Randomised evaluation of the impact of catheter ablation on psychological distress , neurocognitive function, and arrhythmia outcomes in atrial fibrillation

Prof Jonathan Kalman0 个研究点目标入组 100 人开始时间: 2018年1月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 80 Years(—)
性别
All

入选标准

  • Paroxysmal and persistent atrial fibrillation
  • Able to give valid consent

排除标准

  • Severe valvular heart disease
  • Patients treated for suicidal ideation
  • Patients being treated for severe depression, anxiety or mood disorders
  • Pre-existing neurological or clinically evident neurovascular condition
  • Anticipated difficulty with neurocognitive assessment (deafness, language difficulties)
  • Contraindication for systemic anticoagulation
  • Patients who sustain a new cerebrovascular accident during study period
  • Rheumatic mitral valve disease

研究者

发起方
Prof Jonathan Kalman

相似试验